We design affordable, safe and effective drugs to safeguard and empower the brain throughout all stages of life. Our aim is to improve quality of life and longevity. We are creating new approaches to treat mental and behavioral disorders, and to enhance cognitive function in healthy people.

Corporate Governance

Name	Position	Member of the Compensation, Nomination and Governance Committee	Member of the Audit Committee	Independent Director (as defined under Nasdaq Stock Market rules)
Ronald Hafner	Chairman of the Board of Directors	●		●
Alexander Zwyer	Chief Executive Officer and Director
Pascal Brenneisen	Director	●	●	●
Myoung-Ok Kwon, Ph.D.	Director		●
Stig Løkke Pedersen	Director	●	●	●